Beacon Capital Management LLC (Tennessee)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10
Closed -$1.16K 1160
2023
Q4
$1.16K Hold
10
﹤0.01% 853
2023
Q3
$1.03K Hold
10
﹤0.01% 920
2023
Q2
$1.03K Hold
10
﹤0.01% 920
2023
Q1
$1.09K Hold
10
﹤0.01% 834
2022
Q4
$1.14K Hold
10
﹤0.01% 870
2022
Q3
$1K Hold
10
﹤0.01% 867
2022
Q2
$1K Hold
10
﹤0.01% 914
2022
Q1
$1K Buy
+10
New +$975 ﹤0.01% 915

Other funds holding HZNP

Beacon Capital Management LLC (Tennessee)'s HZNP Position: Q1 2024 in Review

Beacon Capital Management LLC (Tennessee) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2024, closing a stake of 10 shares — an estimated $1.16K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in HZNP in Q1 2022 and held it in 8 quarters. The position peaked at $1.16K in Q4 2023. 1 fund tracked by Wall St. Rank holds HZNP as of Q1 2024.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2024 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 10 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2024, an estimated $1.16K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 8 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.16K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2024.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q1 2024, filed 16 May 2024.